国产精品毛片VA无遮挡,精品国产日本在线观看,久久久久久久久国产精品,日本欧美一区人妻中文字幕

掃碼關注公眾號           掃碼咨詢技術支持           掃碼咨詢技術服務
  
客服熱線:400-901-9800  客服QQ:4009019800  技術答疑  技術支持  質量反饋  人才招聘  關于我們  聯(lián)系我們
国产精品日本欧美一区,免费国产三级视频在线观看
首頁 > 產(chǎn)品中心 > 一抗 > 產(chǎn)品信息
Rabbit Anti-E Tag  antibody (bs-2116R)
訂購熱線:400-901-9800
訂購郵箱:sales@m.hebaili.cn
訂購QQ:  400-901-9800
技術支持:techsupport@m.hebaili.cn
說明書: 100ul  500ul  
100ul/980.00元
500ul/4000.00元
大包裝/詢價

產(chǎn)品編號 bs-2116R
英文名稱 Rabbit Anti-E Tag  antibody
中文名稱 E-Tag標簽抗體
別    名 E-Tag;  
產(chǎn)品類型 標簽抗體 
抗體來源 Rabbit
克隆類型 Polyclonal
交叉反應 Recombinant protein
產(chǎn)品應用 WB=1:1000-5000,ELISA=1:5000-10000
not yet tested in other applications.
optimal dilutions/concentrations should be determined by the end user.
性    狀 Liquid
濃    度 1mg/ml
免 疫 原 KLH conjugated E Tag peptide: GAPVPYPDPLEPR 
亞    型 IgG
純化方法 affinity purified by Protein A
緩 沖 液 0.01M TBS (pH7.4) with 1% BSA, 0.02% Proclin300 and 50% Glycerol.
保存條件 Shipped at 4℃. Store at -20℃ for one year. Avoid repeated freeze/thaw cycles.
注意事項 This product as supplied is intended for research use only, not for use in human, therapeutic or diagnostic applications.
PubMed PubMed
產(chǎn)品介紹 E Tag is a commonly used epitope tag engineered onto the N- or C- terminus of a protein of interest so that the tagged protein can be analyzed and visualized. Because of the small size of the epitope, it is unlikely to alter the activity of the cloned sequence.

SWISS:
N/A

Gene ID:
N/A

產(chǎn)品圖片
Sample: Lane1: E-Tagged Fusion Protein Overexpression E.coli Lysate at 2ug Lane2: E-Tagged Fusion Protein Overexpression E.coli Lysate at 2ug Primary: Anti- E tag (bs-2116R) at 1/1000 dilution Secondary: IRDye800CW Goat Anti-Rabbit IgG at 1/20000 dilution Predicted band size: 45 kD Observed band size: 45 kD
版權所有 2004-2026 www.m.hebaili.cn 北京博奧森生物技術有限公司
通過國際質量管理體系ISO 9001:2015 GB/T 19001-2016    證書編號: 00124Q34771R2M/1100
通過國際醫(yī)療器械-質量管理體系ISO 13485:2016 GB/T 42061-2022    證書編號: CQC24QY10047R0M/1100
京ICP備05066980號-1         京公網(wǎng)安備110107000727號
| | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |